Results 101 to 110 of about 48,562 (198)

Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: a meta-analysis

, 2020
Introduction: Janus kinase (JAK) inhibitors are a new class of medication approved for treating rheumatoid arthritis. As JAKs are involved in lipid metabolism, we investigated the cardiovascular safety of JAK inhibitors.
Tsoi, MF, Or, CYB, Cheung, TT, Fei, Y, Cheung, BMY   +4 more
core  

Janus kinase inhibitors clear to land [PDF]

Rheumatology, 2017
openaire   +2 more sources

Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis

Journal of Inflammation Research, 2013
Maurizio Cutolo, Marianna Meroni Research Laboratories and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genova, Italy Abstract: Immune/inflammatory cells act in rheumatoid arthritis (RA)-affected ...
Cutolo M, Meroni M
doaj  

Use of Janus Kinase Inhibitors for Granulomatous Dermatoses: A Systematic Review

Granulomatous dermatoses (GDs) are heterogeneous inflammatory skin conditions involving granuloma formation and macrophage accumulation. While the use of Janus kinase inhibitors (JAKi) for GDs remains novel, this systematic review summarizes the current ...
Sood, S
core   +1 more source

Evaluating the safety of Janus kinase inhibitors in the management of severe immune-related adverse events. [PDF]

J Immunother Cancer
Lee E, Karagenova R, Fuksman L, Katyal P, Lim T, Sun V, Reynolds KL, Semenov YR.   +7 more
europepmc   +1 more source

Janus Kinase Inhibitors and Body Weight: Current Evidence and Potential. [PDF]

Life (Basel)
Kraev K, Basheva-Kraeva Y, Uchikova M, Uchikov P, Hristov B, Valova S, Doykov M, Stanchev D, Boyukliev A, Batalov Z.   +9 more
europepmc   +1 more source

A meta-analysis of the efficacy and safety of Janus kinase inhibitors in patients with ulcerative colitis. [PDF]

Medicine (Baltimore)
Yang Q, Yan Y.
europepmc   +1 more source

Janus Kinase Inhibitors in the Treatment of Crohn’s Disease and Ulcerative Colitis: A Review

Introduction and purpose: Insufficient efficacy and adverse effects of classical therapies for inflammatory bowel disease (IBD), such as ulcerative colitis and Crohn's disease, have prompted the search for new, more targeted treatment methods.
Kacper Ordon, Paulina Szulc, Olimpia Wiciun, Magdalena Badziąg, Olga Kądziołka, Laura Kurczoba, Martyna Kłossowska, Karolina Skonieczna   +7 more
core   +1 more source

Efficacy of abrocitinib in patients with atopic dermatitis resistant to Janus kinase inhibitors. [PDF]

Skin Health Dis
Ippoliti E, Gori N, Coscarella G, Antonelli F, Cannizzaro MV, Peris K.   +5 more
europepmc   +1 more source

Therapeutic Outcomes of Janus Kinase Inhibitors in Refractory Nail Lichen Planus: A Systematic Review. [PDF]

Cureus
Aqeel S, Hannani H, Mojiri ME, Otaif FA, Alsaadi GM, Alghamdi AA, Alammari FF, Alkhudairy SK, Alzahrani HA, Akkam MM.   +9 more
europepmc   +1 more source